15 Apr 2019 --- The US Food and Drug Administration’s (FDA) impending mandatory added sugar labeling policy for packaged foods and beverages – set to take effect between 2020 and 2021 – could prevent or postpone nearly 1 million cases of cardiometabolic disease, including heart disease, stroke and Type 2 diabetes, over a 20 year period. This is according to a study published in Circulation, which highlights how the new label could be a cost-effective way to generate important health gains and cost-savings. The researchers also note the significant role for industry, as modest product reformulation was found to be an impactful way to increase potential benefits.
